IP 254 (Ranitidine 300 mg)
Pill imprint IP 254 has been identified as Ranitidine hydrochloride 300 mg.
Ranitidine is used in the treatment of gerd; zollinger-ellison syndrome; erosive esophagitis; duodenal ulcer; eczema (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 300 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- IP 254
- Strength:
- 300 mg
- Color:
- Yellow
- Shape:
- Capsule-shape
- Availability:
- Rx and/or OTC
- Drug Class:
- H2 antagonists
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Amneal Pharmaceuticals
More about ranitidine
Consumer resources
- Other brands: Zantac, Zantac 150, Zantac 300, Zantac 75, More (4) »
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
